Cargando…

EQUIPT: protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control

INTRODUCTION: Tobacco smoking claims 700 000 lives every year in Europe and the cost of tobacco smoking in the EU is estimated between €98 and €130 billion annually; direct medical care costs and indirect costs such as workday losses each represent half of this amount. Policymakers all across Europe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pokhrel, Subhash, Evers, Silvia, Leidl, Reiner, Trapero-Bertran, Marta, Kalo, Zoltan, de Vries, Hein, Crossfield, Andrea, Andrews, Fiona, Rutter, Ailsa, Coyle, Kathryn, Lester-George, Adam, West, Robert, Owen, Lesley, Jones, Teresa, Vogl, Matthias, Radu-Loghin, Cornel, Voko, Zoltan, Huic, Mirjana, Coyle, Doug
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244438/ https://www.ncbi.nlm.nih.gov/pubmed/25421342 http://dx.doi.org/10.1136/bmjopen-2014-006945

Ejemplares similares

A utility of model input uncertainty analysis in transferring tobacco control‐related economic evidence to countries with scarce resources: results from the EQUIPT study
por: Németh, Bertalan, et al.
Publicado: (2018)

Understanding perceived availability and importance of tobacco control interventions to inform European adoption of a UK economic model: a cross-sectional study
por: Kulchaitanaroaj, Puttarin, et al.
Publicado: (2018)

Development and application of an economic model (EQUIPTMOD) to assess the impact of smoking cessation
por: Coyle, Kathryn, et al.
Publicado: (2017)

Similarities and differences between stakeholders’ opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey
por: Vokó, Zoltan, et al.
Publicado: (2016)

Cost‐effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD
por: Huber, Manuel B., et al.
Publicado: (2017)

Cost‐effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD
por: Trapero‐Bertran, Marta, et al.
Publicado: (2018)

Estimates of costs for modelling return on investment from smoking cessation interventions
por: Trapero‐Bertran, Marta, et al.
Publicado: (2018)

Smoking and health-related quality of life in English general population: implications for economic evaluations
por: Vogl, Matthias, et al.
Publicado: (2012)

HTA Implementation Roadmap in Central and Eastern European Countries
por: Kaló, Zoltán, et al.
Publicado: (2016)

Assessment of cost‐effective changes to the current and potential provision of smoking cessation services: an analysis based on the EQUIPTMOD
por: Anraad, Charlotte, et al.
Publicado: (2018)

Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary
por: Vokó, Zoltán, et al.
Publicado: (2012)

Estimates of effectiveness and reach for ‘return on investment’ modelling of smoking cessation interventions using data from England
por: West, Robert, et al.
Publicado: (2017)

Cost‐effectiveness of possible future smoking cessation strategies in Hungary: results from the EQUIPTMOD
por: Németh, Bertalan, et al.
Publicado: (2018)

Research can be integrated into public health policy-making: global lessons for and from Spanish economic evaluations
por: Trapero-Bertran, Marta, et al.
Publicado: (2022)

Is it cost‐effective to provide internet‐based interventions to complement the current provision of smoking cessation services in the Netherlands? An analysis based on the EQUIPTMOD
por: Cheung, Kei‐Long, et al.
Publicado: (2017)

Pitfalls associated with the therapeutic reference pricing practice of asthma medication
por: Kalo, Zoltan, et al.
Publicado: (2012)

Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region
por: Kaló, Zoltán, et al.
Publicado: (2017)

Is there a fair allocation of healthcare research funds by the European Union?
por: Kaló, Zoltán, et al.
Publicado: (2019)

Tobacco: An accepted pandemic?
por: Radu-Loghin, Cornel
Publicado: (2021)

Benefits Of Timely Care In Pancreatic Cancer: A Systematic Review To Navigate Through The Contradictory Evidence
por: Lukács, Gábor, et al.
Publicado: (2019)

Development of transferability guidance for integrated care models with special focus on Central and Eastern European countries
por: Kaló, Zoltán, et al.
Publicado: (2020)

Cost-Effectiveness of Pharmacological Treatments for Osteoporosis Consistent with the Revised Economic Evaluation Guidelines for Canada
por: Coyle, Doug
Publicado: (2019)

Designing economic evaluations to facilitate optimal decisions: the need to avoid bias
por: Lee, Karen M, et al.
Publicado: (2016)

The effect of social distance measures on COVID-19 epidemics in Europe: an interrupted time series analysis
por: Vokó, Zoltán, et al.
Publicado: (2020)

Completeness and Changes in Registered Data and Reporting Bias of Randomized Controlled Trials in ICMJE Journals after Trial Registration Policy
por: Huić, Mirjana, et al.
Publicado: (2011)

The influence of education on the access to childhood immunization: the case of Spain
por: Mora, T., et al.
Publicado: (2018)

Patient characteristics and valuation changes impact quality of life and satisfaction in total knee arthroplasty – results from a German prospective cohort study
por: Felix, Julia, et al.
Publicado: (2019)

Improved survival of non-small cell lung cancer patients after introducing patient navigation: A retrospective cohort study with propensity score weighted historic control
por: Pitter, János G., et al.
Publicado: (2022)

Costs and effects of intra-operative fluorescence molecular imaging – A model-based, early assessment
por: Präger, Maximilian, et al.
Publicado: (2018)

Epidemiology of Sanfilippo syndrome: results of a systematic literature review
por: Zelei, Tamás, et al.
Publicado: (2018)

Economic impact of HIV/AIDS: a systematic review in five European countries
por: Trapero-Bertran, Marta, et al.
Publicado: (2014)

Effects of and challenges to bans on menthol and other flavors in tobacco products
por: Przewoźniak, Krzysztof, et al.
Publicado: (2021)

Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges
por: Daubner-Bendes, Rita, et al.
Publicado: (2021)

Determining utility values related to malaria and malaria chemoprophylaxis
por: McCarthy, Anne E, et al.
Publicado: (2010)

Reducing Periconceptional Methylmercury Exposure: Cost–Utility Analysis for a Proposed Screening Program for Women Planning a Pregnancy in Ontario, Canada
por: Gaskin, Janet, et al.
Publicado: (2015)

Restenosis rates in patients with ipsilateral carotid endarterectomy and contralateral carotid artery stenting
por: Nguyen, Dat Tin, et al.
Publicado: (2022)

Can cost–effectiveness principles be ignored in urgent times?
por: Kaló, Zoltán, et al.
Publicado: (2021)

Lectures on contemporary probability
por: Lawler, Gregory F, et al.
Publicado: (1999)

Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals
por: Szekanecz, Zoltán, et al.
Publicado: (2023)

What Guidance Are Researchers Given on How to Present Network Meta-Analyses to End-Users such as Policymakers and Clinicians? A Systematic Review
por: Sullivan, Shannon M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tp1942cdbl535haggleivh3rdl